2015-2025 Global Benign Prostatic Hyperplasia (BPH) Drugs Market Research by Type, End-Use and Region (COVID-19 Version)

June 2020 | 142 pages | ID: 29810BD36F2BEN
99Strategy

Abstracts

SUMMARY


The global Benign Prostatic Hyperplasia (BPH) Drugs market is expected to reach xxx Million USD by 2025, with a CAGR of xx% from 2020 to 2025.

Further key aspects of the report indicate that:

• Chapter 1: Market Definition and Segment by Type, End-Use & Major Regions Market Size
• Chapter 2: Global Production & Consumption Market by Type and End-Use
• Chapter 3: Europe Production & Consumption Market by Type and End-Use
• Chapter 4: America Production & Consumption Market by Type and End-Use
• Chapter 5: Asia Production & Consumption Market by Type and End-Use
• Chapter 6: Oceania Production & Consumption Market by Type and End-Use
• Chapter 7: Africa Production & Consumption Market by Type and End-Use
• Chapter 8: Global Market Forecast by Type, End-Use and Region
• Chapter 9: Company information, Sales, Cost, Margin, news etc.
• Chapter 10: Market Competition by Companies and Market Concentration Ratio
• Chapter 11: Market Impact by Coronavirus.
• Chapter 12: Industry Summary

Market Segment as follows:

Key Companies

• Astellas Pharma
• Eli Lilly
• GlaxoSmithKline
• Sanofi
• ADC Therapeutics
• Bayer HealthCare
• Bristol-Myers Squibb
• Valeant Pharmaceuticals
• Endo Pharmaceuticals
• Foresee Pharmaceuticals
• Madrigal Pharmaceuticals
• Merck
• Novartis
• Spectrum Pharmaceuticals
• Takeda Pharmaceuticals
• Teva
• Advaxis
• ANI Pharmaceuticals
• BHR Pharma

Key Types

• Alpha-blocker
• Phosphodiesterase Type-5 Inhibitors
• 5-alpha-Reductase Inhibitors

Key End-Use

• Hospitals
• Clinics
• Others

This report can be dispatched within 48-72 Hours.

Contents

CHAPTER 1 MARKET OVERVIEW

1.1 Market Definition and Segment
  1.1.1 Product Definition
  1.1.2 Product Type
  1.1.3 End-Use
  1.1.4 Marketing Channel
1.2 Major Regions
  1.2.1 Europe Market Size and Growth
Figure Europe Benign Prostatic Hyperplasia (BPH) Drugs Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Europe Benign Prostatic Hyperplasia (BPH) Drugs Market Forecast and Growth Rate, 2020E-2025F (Million USD)
  1.2.2 America Market Size and Growth
Figure America Benign Prostatic Hyperplasia (BPH) Drugs Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure America Benign Prostatic Hyperplasia (BPH) Drugs Market Forecast and Growth Rate, 2020E-2025F (Million USD)
  1.2.3 Asia Market Size and Growth
Figure Asia Benign Prostatic Hyperplasia (BPH) Drugs Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure AsiaBenign Prostatic Hyperplasia (BPH) Drugs Market Forecast and Growth Rate, 2020E-2025F (Million USD)
  1.2.4 Oceania Market Size and Growth
Figure Oceania Benign Prostatic Hyperplasia (BPH) Drugs Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Oceania Benign Prostatic Hyperplasia (BPH) Drugs Market Forecast and Growth Rate, 2020E-2025F (Million USD)
  1.2.5 Africa Market Size and Growth
Figure Africa Benign Prostatic Hyperplasia (BPH) Drugs Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Africa Benign Prostatic Hyperplasia (BPH) Drugs Market Forecast and Growth Rate, 2020E-2025F (Million USD)

CHAPTER 2 GLOBAL MARKET SEGMENTATION

2.1 Global Production Overview
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
2.2 Global Consumption Overview
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
2.3 Global Production by Type
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue by Type, 2015-2020 (Million USD)
Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue Share by Type in 2020 (Million USD)
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Production Volume by Type, 2015-2020 (Volume)
Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Production Volume Share by Type in 2020 (Volume)
2.4 Global Consumption by End-Use
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Consumption Value Share by End-Use in 2020 (Million USD)
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Consumption Volume Share by End-Use in 2020 (Volume)
2.5 Global Consumption by Region
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Consumption Volume by Region, 2015-2020 (Volume)

CHAPTER 3 EUROPE MARKET SEGMENTATION

3.1 Europe Production Overview
Table Europe Benign Prostatic Hyperplasia (BPH) Drugs Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
3.2 Europe Consumption Overview
Table Europe Benign Prostatic Hyperplasia (BPH) Drugs Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
3.3 Europe Production by Type
Table Europe Benign Prostatic Hyperplasia (BPH) Drugs Revenue by Type, 2015-2020 (Million USD)
Figure Europe Benign Prostatic Hyperplasia (BPH) Drugs Revenue Share by Type in 2020 (Million USD)
Table Europe Benign Prostatic Hyperplasia (BPH) Drugs Production Volume by Type, 2015-2020 (Volume)
Figure Europe Benign Prostatic Hyperplasia (BPH) Drugs Production Volume Share by Type in 2020 (Volume)
3.4 Europe Consumption by End-Use
Table Europe Benign Prostatic Hyperplasia (BPH) Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Europe Benign Prostatic Hyperplasia (BPH) Drugs Consumption Value Share by End-Use in 2020 (Million USD)
Table Europe Benign Prostatic Hyperplasia (BPH) Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Europe Benign Prostatic Hyperplasia (BPH) Drugs Consumption Volume Share by End-Use in 2020 (Volume)
3.5 Europe Consumption by Region
Table Europe Benign Prostatic Hyperplasia (BPH) Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table Europe Benign Prostatic Hyperplasia (BPH) Drugs Consumption Volume by Region, 2015-2020 (Volume)

CHAPTER 4 AMERICA MARKET SEGMENTATION

4.1 America Production Overview
Table America Benign Prostatic Hyperplasia (BPH) Drugs Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
4.2 America Consumption Overview
Table America Benign Prostatic Hyperplasia (BPH) Drugs Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
4.3 America Production by Type
Table America Benign Prostatic Hyperplasia (BPH) Drugs Revenue by Type, 2015-2020 (Million USD)
Figure America Benign Prostatic Hyperplasia (BPH) Drugs Revenue Share by Type in 2020 (Million USD)
Table America Benign Prostatic Hyperplasia (BPH) Drugs Production Volume by Type, 2015-2020 (Volume)
Figure America Benign Prostatic Hyperplasia (BPH) Drugs Production Volume Share by Type in 2020 (Volume)
4.4 America Consumption by End-Use
Table America Benign Prostatic Hyperplasia (BPH) Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Figure America Benign Prostatic Hyperplasia (BPH) Drugs Consumption Value Share by End-Use in 2020 (Million USD)
Table America Benign Prostatic Hyperplasia (BPH) Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Figure America Benign Prostatic Hyperplasia (BPH) Drugs Consumption Volume Share by End-Use in 2020 (Volume)
4.5 America Consumption by Region
Table America Benign Prostatic Hyperplasia (BPH) Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table America Benign Prostatic Hyperplasia (BPH) Drugs Consumption Volume by Region, 2015-2020 (Volume)

CHAPTER 5 ASIA MARKET SEGMENTATION

5.1 Asia Production Overview
Table Asia Benign Prostatic Hyperplasia (BPH) Drugs Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
5.2 Asia Consumption Overview
Table Asia Benign Prostatic Hyperplasia (BPH) Drugs Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
5.3 Asia Production by Type
Table Asia Benign Prostatic Hyperplasia (BPH) Drugs Revenue by Type, 2015-2020 (Million USD)
Figure Asia Benign Prostatic Hyperplasia (BPH) Drugs Revenue Share by Type in 2020 (Million USD)
Table Asia Benign Prostatic Hyperplasia (BPH) Drugs Production Volume by Type, 2015-2020 (Volume)
Figure Asia Benign Prostatic Hyperplasia (BPH) Drugs Production Volume Share by Type in 2020 (Volume)
5.4 Asia Consumption by End-Use
Table Asia Benign Prostatic Hyperplasia (BPH) Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Asia Benign Prostatic Hyperplasia (BPH) Drugs Consumption Value Share by End-Use in 2020 (Million USD)
Table Asia Benign Prostatic Hyperplasia (BPH) Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Asia Benign Prostatic Hyperplasia (BPH) Drugs Consumption Volume Share by End-Use in 2020 (Volume)
5.5 Asia Consumption by Region
Table Asia Benign Prostatic Hyperplasia (BPH) Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table Asia Benign Prostatic Hyperplasia (BPH) Drugs Consumption Volume by Region, 2015-2020 (Volume)

CHAPTER 6 OCEANIA MARKET SEGMENTATION

6.1 Oceania Production Overview
Table Oceania Benign Prostatic Hyperplasia (BPH) Drugs Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
6.2 Oceania Consumption Overview
Table Oceania Benign Prostatic Hyperplasia (BPH) Drugs Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
6.3 Oceania Production by Type
Table Oceania Benign Prostatic Hyperplasia (BPH) Drugs Revenue by Type, 2015-2020 (Million USD)
Figure Oceania Benign Prostatic Hyperplasia (BPH) Drugs Revenue Share by Type in 2020 (Million USD)
Table Oceania Benign Prostatic Hyperplasia (BPH) Drugs Production Volume by Type, 2015-2020 (Volume)
Figure Oceania Benign Prostatic Hyperplasia (BPH) Drugs Production Volume Share by Type in 2020 (Volume)
6.4 Oceania Consumption by End-Use
Table Oceania Benign Prostatic Hyperplasia (BPH) Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Oceania Benign Prostatic Hyperplasia (BPH) Drugs Consumption Value Share by End-Use in 2020 (Million USD)
Table Oceania Benign Prostatic Hyperplasia (BPH) Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Oceania Benign Prostatic Hyperplasia (BPH) Drugs Consumption Volume Share by End-Use in 2020 (Volume)
6.5 Oceania Consumption by Region
Table Oceania Benign Prostatic Hyperplasia (BPH) Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table Oceania Benign Prostatic Hyperplasia (BPH) Drugs Consumption Volume by Region, 2015-2020 (Volume)

CHAPTER 7 AFRICA MARKET SEGMENTATION

7.1 Africa Production Overview
Table Africa Benign Prostatic Hyperplasia (BPH) Drugs Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
7.2 Africa Consumption Overview
Table Africa Benign Prostatic Hyperplasia (BPH) Drugs Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
7.3 Africa Production by Type
Table Africa Benign Prostatic Hyperplasia (BPH) Drugs Revenue by Type, 2015-2020 (Million USD)
Figure Africa Benign Prostatic Hyperplasia (BPH) Drugs Revenue Share by Type in 2020 (Million USD)
Table Africa Benign Prostatic Hyperplasia (BPH) Drugs Production Volume by Type, 2015-2020 (Volume)
Figure Africa Benign Prostatic Hyperplasia (BPH) Drugs Production Volume Share by Type in 2020 (Volume)
7.4 Africa Consumption by End-Use
Table Africa Benign Prostatic Hyperplasia (BPH) Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Africa Benign Prostatic Hyperplasia (BPH) Drugs Consumption Value Share by End-Use in 2020 (Million USD)
Table Africa Benign Prostatic Hyperplasia (BPH) Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Africa Benign Prostatic Hyperplasia (BPH) Drugs Consumption Volume Share by End-Use in 2020 (Volume)
7.5 Africa Consumption by Region
Table Africa Benign Prostatic Hyperplasia (BPH) Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table Africa Benign Prostatic Hyperplasia (BPH) Drugs Consumption Volume by Region, 2015-2020 (Volume)

CHAPTER 8 GLOBAL MARKET FORECAST

8.1 Global Benign Prostatic Hyperplasia (BPH) Drugs Production Forecast
Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue and Growth Rate Forecast 2020E-2025F (Million USD)
Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Production Volume and Growth Rate Forecast 2020E-2025F (Volume)
8.2 Global Benign Prostatic Hyperplasia (BPH) Drugs Forecast by Type
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue by Type, 2020E-2025F (Million USD)
Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue Share by Type in 2025 (Million USD)
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Production Volume by Type, 2020E-2025F (Volume)
Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Production Volume Share by Type in 2025 (Volume)
8.3 Global Benign Prostatic Hyperplasia (BPH) Drugs Forecast by End-Use (2020E-2025F)
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Consumption Value by End-Use, 2020E-2025F (Million USD)
Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Consumption Value Share by End-Use in 2025 (Million USD)
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Consumption Volume by End-Use, 2020E-2025F (Volume)
8.4 Global Benign Prostatic Hyperplasia (BPH) Drugs Forecast by Region (2020E-2025F)
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Consumption Value by Region, 2020E-2025F (Million USD)
Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Consumption Value Share by Region in 2025 (Million USD)
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Consumption Volume by Region, 2020E-2025F (Volume)
Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Consumption Volume Share by Region in 2025 (Volume)

CHAPTER 9 GLOBAL MAJOR COMPANIES LIST

9.1 Astellas Pharma
  9.1.1 Astellas Pharma Profile
Table Astellas Pharma Overview List
  9.1.2 Astellas Pharma Products & Services
  9.1.3 Astellas Pharma Company Dynamics & News
  9.1.4 Astellas Pharma Business Operation Conditions
Table Business Operation of Astellas Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.2 Eli Lilly
  9.2.1 Eli Lilly Profile
Table Eli Lilly Overview List
  9.2.2 Eli Lilly Products & Services
  9.2.3 Eli Lilly Company Dynamics & News
  9.2.4 Eli Lilly Business Operation Conditions
Table Business Operation of Eli Lilly (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.3 GlaxoSmithKline
  9.3.1 GlaxoSmithKline Profile
Table GlaxoSmithKline Overview List
  9.3.2 GlaxoSmithKline Products & Services
  9.3.3 GlaxoSmithKline Company Dynamics & News
  9.3.4 GlaxoSmithKline Business Operation Conditions
Table Business Operation of GlaxoSmithKline (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.4 Sanofi
  9.4.1 Sanofi Profile
Table Sanofi Overview List
  9.4.2 Sanofi Products & Services
  9.4.3 Sanofi Company Dynamics & News
  9.4.4 Sanofi Business Operation Conditions
Table Business Operation of Sanofi (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.5 ADC Therapeutics
  9.5.1 ADC Therapeutics Profile
Table ADC Therapeutics Overview List
  9.5.2 ADC Therapeutics Products & Services
  9.5.3 ADC Therapeutics Company Dynamics & News
  9.5.4 ADC Therapeutics Business Operation Conditions
Table Business Operation of ADC Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.6 Bayer HealthCare
  9.6.1 Bayer HealthCare Profile
Table Bayer HealthCare Overview List
  9.6.2 Bayer HealthCare Products & Services
  9.6.3 Bayer HealthCare Company Dynamics & News
  9.6.4 Bayer HealthCare Business Operation Conditions
Table Business Operation of Bayer HealthCare (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.7 Bristol-Myers Squibb
  9.7.1 Bristol-Myers Squibb Profile
Table Bristol-Myers Squibb Overview List
  9.7.2 Bristol-Myers Squibb Products & Services
  9.7.3 Bristol-Myers Squibb Company Dynamics & News
  9.7.4 Bristol-Myers Squibb Business Operation Conditions
Table Business Operation of Bristol-Myers Squibb (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.8 Valeant Pharmaceuticals
  9.8.1 Valeant Pharmaceuticals Profile
Table Valeant Pharmaceuticals Overview List
  9.8.2 Valeant Pharmaceuticals Products & Services
  9.8.3 Valeant Pharmaceuticals Company Dynamics & News
  9.8.4 Valeant Pharmaceuticals Business Operation Conditions
Table Business Operation of Valeant Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.9 Endo Pharmaceuticals
  9.9.1 Endo Pharmaceuticals Profile
Table Endo Pharmaceuticals Overview List
  9.9.2 Endo Pharmaceuticals Products & Services
  9.9.3 Endo Pharmaceuticals Company Dynamics & News
  9.9.4 Endo Pharmaceuticals Business Operation Conditions
Table Business Operation of Endo Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.10 Foresee Pharmaceuticals
  9.10.1 Foresee Pharmaceuticals Profile
Table Foresee Pharmaceuticals Overview List
  9.10.2 Foresee Pharmaceuticals Products & Services
  9.10.3 Foresee Pharmaceuticals Company Dynamics & News
  9.10.4 Foresee Pharmaceuticals Business Operation Conditions
Table Business Operation of Foresee Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.11 Madrigal Pharmaceuticals
  9.11.1 Madrigal Pharmaceuticals Profile
Table Madrigal Pharmaceuticals Overview List
  9.11.2 Madrigal Pharmaceuticals Products & Services
  9.11.3 Madrigal Pharmaceuticals Company Dynamics & News
  9.11.4 Madrigal Pharmaceuticals Business Operation Conditions
Table Business Operation of Madrigal Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.12 Merck
  9.12.1 Merck Profile
Table Merck Overview List
  9.12.2 Merck Products & Services
  9.12.3 Merck Company Dynamics & News
  9.12.4 Merck Business Operation Conditions
Table Business Operation of Merck (Sales Revenue, Cost, Gross Margin)
9.13 Novartis
  9.13.1 Novartis Profile
Table Novartis Overview List
  9.13.2 Novartis Products & Services
  9.13.3 Novartis Company Dynamics & News
  9.13.4 Novartis Business Operation Conditions
Table Business Operation of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.14 Spectrum Pharmaceuticals
  9.14.1 Spectrum Pharmaceuticals Profile
Table Spectrum Pharmaceuticals Overview List
  9.14.2 Spectrum Pharmaceuticals Products & Services
  9.14.3 Spectrum Pharmaceuticals Company Dynamics & News
  9.14.4 Spectrum Pharmaceuticals Business Operation Conditions
Table Business Operation of Spectrum Pharmaceuticals (Sales Revenue, Cost, Gross Margin)
9.15 Takeda Pharmaceuticals
  9.15.1 Takeda Pharmaceuticals Profile
Table Takeda Pharmaceuticals Overview List
  9.15.2 Takeda Pharmaceuticals Products & Services
  9.15.3 Takeda Pharmaceuticals Company Dynamics & News
  9.15.4 Takeda Pharmaceuticals Business Operation Conditions
Table Business Operation of Takeda Pharmaceuticals (Sales Revenue, Cost, Gross Margin)
9.16 Teva
  9.16.1 Teva Profile
Table Teva Overview List
  9.16.2 Teva Products & Services
  9.16.3 Teva Company Dynamics & News
  9.16.4 Teva Business Operation Conditions
Table Business Operation of Teva (Sales Revenue, Cost, Gross Margin)
9.17 Advaxis
  9.17.1 Advaxis Profile
Table Advaxis Overview List
  9.17.2 Advaxis Products & Services
  9.17.3 Advaxis Company Dynamics & News
  9.17.4 Advaxis Business Operation Conditions
Table Business Operation of Advaxis (Sales Revenue, Cost, Gross Margin)
9.18 ANI Pharmaceuticals
  9.18.1 ANI Pharmaceuticals Profile
Table ANI Pharmaceuticals Overview List
  9.18.2 ANI Pharmaceuticals Products & Services
  9.18.3 ANI Pharmaceuticals Company Dynamics & News
  9.18.4 ANI Pharmaceuticals Business Operation Conditions
Table Business Operation of ANI Pharmaceuticals (Sales Revenue, Cost, Gross Margin)
9.19 BHR Pharma
  9.19.1 BHR Pharma Profile
Table BHR Pharma Overview List
  9.19.2 BHR Pharma Products & Services
  9.19.3 BHR Pharma Company Dynamics & News
  9.19.4 BHR Pharma Business Operation Conditions
Table Business Operation of BHR Pharma (Sales Revenue, Cost, Gross Margin)

PART 10 MARKET COMPETITION

10.1 Key Company Market Share
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Sales Revenue 2015-2020E, by Companies, in USD Million
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Sales Revenue Share, 2015-2020E, by Companies, in USD
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume by Companies, 2015-2020E (Volume)
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume Share by Companies, 2015-2020E (Volume)
10.2 Regional Market Concentration
Figure Europe Benign Prostatic Hyperplasia (BPH) Drugs Market Concentration Ratio in 2020E
Figure America Benign Prostatic Hyperplasia (BPH) Drugs Market Concentration Ratio in 2020E
Figure Asia Benign Prostatic Hyperplasia (BPH) Drugs Market Concentration Ratio in 2020E
Figure Oceania Benign Prostatic Hyperplasia (BPH) Drugs Market Concentration Ratio in 2020E
Figure Africa Benign Prostatic Hyperplasia (BPH) Drugs Market Concentration Ratio in 2020E

PART 11 CORONAVIRUS IMPACT ON BENIGN PROSTATIC HYPERPLASIA (BPH) DRUGS INDUSTRY

11.1 Impact on Industry Upstream
11.2 Impact on Industry Downstream
11.3 Impact on Industry Channels
11.4 Impact on Industry Competition
11.5 Impact on Industry Obtain Employment

PART 12 BENIGN PROSTATIC HYPERPLASIA (BPH) DRUGS INDUSTRY SUMMARY & CONCLUSION

List Of Tables

LIST OF TABLES
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue by Type, 2015-2020 (Million USD)
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Production Volume by Type, 2015-2020 (Volume)
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Consumption Volume by Region, 2015-2020 (Volume)
Table Europe Benign Prostatic Hyperplasia (BPH) Drugs Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Europe Benign Prostatic Hyperplasia (BPH) Drugs Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Europe Benign Prostatic Hyperplasia (BPH) Drugs Revenue by Type, 2015-2020 (Million USD)
Table Europe Benign Prostatic Hyperplasia (BPH) Drugs Production Volume by Type, 2015-2020 (Volume)
Table Europe Benign Prostatic Hyperplasia (BPH) Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Table Europe Benign Prostatic Hyperplasia (BPH) Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Table Europe Benign Prostatic Hyperplasia (BPH) Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table Europe Benign Prostatic Hyperplasia (BPH) Drugs Consumption Volume by Region, 2015-2020 (Volume)
Table America Benign Prostatic Hyperplasia (BPH) Drugs Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table America Benign Prostatic Hyperplasia (BPH) Drugs Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table America Benign Prostatic Hyperplasia (BPH) Drugs Revenue by Type, 2015-2020 (Million USD)
Table America Benign Prostatic Hyperplasia (BPH) Drugs Production Volume by Type, 2015-2020 (Volume)
Table America Benign Prostatic Hyperplasia (BPH) Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Table America Benign Prostatic Hyperplasia (BPH) Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Table America Benign Prostatic Hyperplasia (BPH) Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table America Benign Prostatic Hyperplasia (BPH) Drugs Consumption Volume by Region, 2015-2020 (Volume)
Table Asia Benign Prostatic Hyperplasia (BPH) Drugs Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Asia Benign Prostatic Hyperplasia (BPH) Drugs Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Asia Benign Prostatic Hyperplasia (BPH) Drugs Revenue by Type, 2015-2020 (Million USD)
Table Asia Benign Prostatic Hyperplasia (BPH) Drugs Production Volume by Type, 2015-2020 (Volume)
Table Asia Benign Prostatic Hyperplasia (BPH) Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Table Asia Benign Prostatic Hyperplasia (BPH) Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Table Asia Benign Prostatic Hyperplasia (BPH) Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table Asia Benign Prostatic Hyperplasia (BPH) Drugs Consumption Volume by Region, 2015-2020 (Volume)
Table Oceania Benign Prostatic Hyperplasia (BPH) Drugs Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Oceania Benign Prostatic Hyperplasia (BPH) Drugs Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Oceania Benign Prostatic Hyperplasia (BPH) Drugs Revenue by Type, 2015-2020 (Million USD)
Table Oceania Benign Prostatic Hyperplasia (BPH) Drugs Production Volume by Type, 2015-2020 (Volume)
Table Oceania Benign Prostatic Hyperplasia (BPH) Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Table Oceania Benign Prostatic Hyperplasia (BPH) Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Table Oceania Benign Prostatic Hyperplasia (BPH) Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table Oceania Benign Prostatic Hyperplasia (BPH) Drugs Consumption Volume by Region, 2015-2020 (Volume)
Table Africa Benign Prostatic Hyperplasia (BPH) Drugs Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Africa Benign Prostatic Hyperplasia (BPH) Drugs Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Africa Benign Prostatic Hyperplasia (BPH) Drugs Revenue by Type, 2015-2020 (Million USD)
Table Africa Benign Prostatic Hyperplasia (BPH) Drugs Production Volume by Type, 2015-2020 (Volume)
Table Africa Benign Prostatic Hyperplasia (BPH) Drugs Consumption Value by End-Use, 2015-2020 (Million USD)
Table Africa Benign Prostatic Hyperplasia (BPH) Drugs Consumption Volume by End-Use, 2015-2020 (Volume)
Table Africa Benign Prostatic Hyperplasia (BPH) Drugs Consumption Value by Region, 2015-2020 (Million USD)
Table Africa Benign Prostatic Hyperplasia (BPH) Drugs Consumption Volume by Region, 2015-2020 (Volume)
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue by Type, 2020E-2025F (Million USD)
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Production Volume by Type, 2020E-2025F (Volume)
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Consumption Value by End-Use, 2020E-2025F (Million USD)
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Consumption Volume by End-Use, 2020E-2025F (Volume)
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Consumption Value by Region, 2020E-2025F (Million USD)
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Consumption Volume by Region, 2020E-2025F (Volume)
Table Astellas Pharma Overview List
Table Business Operation of Astellas Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Eli Lilly Overview List
Table Business Operation of Eli Lilly (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table GlaxoSmithKline Overview List
Table Business Operation of GlaxoSmithKline (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sanofi Overview List
Table Business Operation of Sanofi (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table ADC Therapeutics Overview List
Table Business Operation of ADC Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Bayer HealthCare Overview List
Table Business Operation of Bayer HealthCare (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Bristol-Myers Squibb Overview List
Table Business Operation of Bristol-Myers Squibb (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Valeant Pharmaceuticals Overview List
Table Business Operation of Valeant Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Endo Pharmaceuticals Overview List
Table Business Operation of Endo Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Foresee Pharmaceuticals Overview List
Table Business Operation of Foresee Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Madrigal Pharmaceuticals Overview List
Table Business Operation of Madrigal Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Merck Overview List
Table Business Operation of Merck (Sales Revenue, Cost, Gross Margin)
Table Novartis Overview List
Table Business Operation of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Spectrum Pharmaceuticals Overview List
Table Business Operation of Spectrum Pharmaceuticals (Sales Revenue, Cost, Gross Margin)
Table Takeda Pharmaceuticals Overview List
Table Business Operation of Takeda Pharmaceuticals (Sales Revenue, Cost, Gross Margin)
Table Teva Overview List
Table Business Operation of Teva (Sales Revenue, Cost, Gross Margin)
Table Advaxis Overview List
Table Business Operation of Advaxis (Sales Revenue, Cost, Gross Margin)
Table ANI Pharmaceuticals Overview List
Table Business Operation of ANI Pharmaceuticals (Sales Revenue, Cost, Gross Margin)
Table BHR Pharma Overview List
Table Business Operation of BHR Pharma (Sales Revenue, Cost, Gross Margin)
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Sales Revenue 2015-2020E, by Companies, in USD Million
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Sales Revenue Share, 2015-2020E, by Companies, in USD
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume by Companies, 2015-2020E (Volume)
Table Global Benign Prostatic Hyperplasia (BPH) Drugs Sales Volume Share by Companies, 2015-2020E (Volume)

List Of Figures

LIST OF FIGURES
Figure Europe Benign Prostatic Hyperplasia (BPH) Drugs Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Europe Benign Prostatic Hyperplasia (BPH) Drugs Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure America Benign Prostatic Hyperplasia (BPH) Drugs Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure America Benign Prostatic Hyperplasia (BPH) Drugs Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Asia Benign Prostatic Hyperplasia (BPH) Drugs Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure AsiaBenign Prostatic Hyperplasia (BPH) Drugs Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Oceania Benign Prostatic Hyperplasia (BPH) Drugs Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Oceania Benign Prostatic Hyperplasia (BPH) Drugs Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Africa Benign Prostatic Hyperplasia (BPH) Drugs Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Africa Benign Prostatic Hyperplasia (BPH) Drugs Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue Share by Type in 2020 (Million USD)
Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Production Volume Share by Type in 2020 (Volume)
Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Consumption Value Share by End-Use in 2020 (Million USD)
Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Consumption Volume Share by End-Use in 2020 (Volume)
Figure Europe Benign Prostatic Hyperplasia (BPH) Drugs Revenue Share by Type in 2020 (Million USD)
Figure Europe Benign Prostatic Hyperplasia (BPH) Drugs Production Volume Share by Type in 2020 (Volume)
Figure Europe Benign Prostatic Hyperplasia (BPH) Drugs Consumption Value Share by End-Use in 2020 (Million USD)
Figure Europe Benign Prostatic Hyperplasia (BPH) Drugs Consumption Volume Share by End-Use in 2020 (Volume)
Figure America Benign Prostatic Hyperplasia (BPH) Drugs Revenue Share by Type in 2020 (Million USD)
Figure America Benign Prostatic Hyperplasia (BPH) Drugs Production Volume Share by Type in 2020 (Volume)
Figure America Benign Prostatic Hyperplasia (BPH) Drugs Consumption Value Share by End-Use in 2020 (Million USD)
Figure America Benign Prostatic Hyperplasia (BPH) Drugs Consumption Volume Share by End-Use in 2020 (Volume)
Figure Asia Benign Prostatic Hyperplasia (BPH) Drugs Revenue Share by Type in 2020 (Million USD)
Figure Asia Benign Prostatic Hyperplasia (BPH) Drugs Production Volume Share by Type in 2020 (Volume)
Figure Asia Benign Prostatic Hyperplasia (BPH) Drugs Consumption Value Share by End-Use in 2020 (Million USD)
Figure Asia Benign Prostatic Hyperplasia (BPH) Drugs Consumption Volume Share by End-Use in 2020 (Volume)
Figure Oceania Benign Prostatic Hyperplasia (BPH) Drugs Revenue Share by Type in 2020 (Million USD)
Figure Oceania Benign Prostatic Hyperplasia (BPH) Drugs Production Volume Share by Type in 2020 (Volume)
Figure Oceania Benign Prostatic Hyperplasia (BPH) Drugs Consumption Value Share by End-Use in 2020 (Million USD)
Figure Oceania Benign Prostatic Hyperplasia (BPH) Drugs Consumption Volume Share by End-Use in 2020 (Volume)
Figure Africa Benign Prostatic Hyperplasia (BPH) Drugs Revenue Share by Type in 2020 (Million USD)
Figure Africa Benign Prostatic Hyperplasia (BPH) Drugs Production Volume Share by Type in 2020 (Volume)
Figure Africa Benign Prostatic Hyperplasia (BPH) Drugs Consumption Value Share by End-Use in 2020 (Million USD)
Figure Africa Benign Prostatic Hyperplasia (BPH) Drugs Consumption Volume Share by End-Use in 2020 (Volume)
Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue and Growth Rate Forecast 2020E-2025F (Million USD)
Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Production Volume and Growth Rate Forecast 2020E-2025F (Volume)
Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue Share by Type in 2025 (Million USD)
Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Production Volume Share by Type in 2025 (Volume)
Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Consumption Value Share by End-Use in 2025 (Million USD)
Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Consumption Value Share by Region in 2025 (Million USD)
Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Consumption Volume Share by Region in 2025 (Volume)